Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Karolinska Institutet
Gruppo Oncologico Italiano di Ricerca Clinica
Beijing Tiantan Hospital
Second Xiangya Hospital of Central South University
Sun Yat-sen University
Associazione Qol-one
Grupo Cooperativo de HemopatÃas Malignas
Tang-Du Hospital
Shanghai Junshi Bioscience Co., Ltd.
Fudan University
Trans Tasman Radiation Oncology Group
Samsung Medical Center
L'Hospitalet de Llobregat
Soon Chun Hyang University
Trans Tasman Radiation Oncology Group